Trial Profile
An efficacy and tolerability study of adjunctive treatment of perampanel for refractory epilepsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Feb 2016
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Therapeutic Use
- 25 Feb 2016 New trial record